ROSSARI BIOTECH
|
|
BOM : 543213     NSE : ROSSARI     | |
LT :  
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive] Debt : Low |
Updated: |
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward Pledged Shares : None or < 25% |
May 27,2022 |
Price(EOD): ₹ 888.20
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
|
Chemicals |
MCap: ₹ 4,893.98 Cr |
Industry Peers & Returns | 1W | 1M | 1Y |
ROSSARI BIOTECH | 0.1% | -5.5% | -28.4% |
PIDILITE INDUSTRIES | -1.1% | -10.4% | 4.1% |
AARTI INDUSTRIES | 0.2% | -12.6% | -9.4% |
DEEPAK NITRITE | -2.3% | -15.9% | 2.4% |
ATUL | 0.6% | -8.9% | -7.4% |
ALKYL AMINES CHEMICALS | -5.1% | -15.8% | -28.7% |
TATA CHEMICALS | -3.7% | -2.9% | 32.4% |
NAVIN FLUORINE INTERNATIONAL | 0.1% | -6.9% | 9.8% |
GODREJ INDUSTRIES | 8.2% | -0.4% | -20.7% |
FUNDAMENTAL ANALYSIS OF ROSSARI BIOTECH
 Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
VALUATION OF ROSSARI BIOTECH
 Ratio | Consolidated | |
---|---|---|
P/E P/B P/S |
57.49
P/E Calculated based on EPS of 15.45
[ Mar2021 - Consolidated Results ] 11.34
P/B Calculated based on Book Value of 78.31
[ Mar2021 - Consolidated Results ] 3.3
P/S Calculated based on Revenues of 1482.97 Cr
[ TTM - Consolidated Results ] |
|
Financial Ratios → |
Model | Discount(-)/ Premium(+) |
---|---|
EV/EBIDTA EV/Sales Price/Sales |
1041% 1266% -63% |
SHARE PRICE MOMENTUM OF ROSSARI BIOTECH
ROSSARI BIOTECH vs SENSEX
DEBT OF ROSSARI BIOTECH
Year | Debt/Equity ratio | |
---|---|---|
Standalone | Consolidated | |
2021 2020 2019 Avg_3yrs |
0 0.24 0.05 0.1 |
0 0.23 0.04 0.09 |
[Last Annual Data : Mar2021]
|
||
Financial Ratios → |
PLEDGED PROMOTER SHARES OF ROSSARI BIOTECH
Pledged Promoter Shares |
0 % | |
---|---|---|
As on : Mar2022 | ||
If less than 25% | Good |
|
If between 25% and 50% | Neutral | |
If greater than 50% | Bad | |
Shareholding Pattern → |
QTRLY RESULTS OF ROSSARI BIOTECH
Consolidated | Q-o-Q | Y-o-Y |
---|---|---|
Revenue Op Profit Profit Before Tax Profit After Tax |
2.45% 11.91% 3.62% 1.66% |
101.14% 45.08% 10.15% 2.47% |
QtrlyTrend |
8 | |
Latest Qtr: Mar2022 | ||
Quarterly Result Analysis → |
ROSSARI BIOTECH related INDICES
BSE Indices | 1W | 1M | 1Y |
---|---|---|---|
S&P BSE 500 | -0.1% | -6.8% | 7.2% |
S&P BSE ALLCAP | -0.3% | -7.1% | 7.5% |
S&P BSE 400 MIDSMALLCAP | -1.3% | -9.3% | 7.2% |
S&P BSE MIDSMALLCAP | -1.5% | -10.1% | 7.1% |
S&P BSE SMALL CAP | -2.8% | -11.4% | 10% |
S&P BSE 250 SMALLCAP | -2.9% | -12.2% | 6% |
S&P BSE BASIC MATERIALS | -5.1% | -14.5% | -1.3% |
NSE Indices | 1W | 1M | 1Y |
---|---|---|---|
NIFTY 500 | -0.2% | -6.9% | 7% |
NIFTY500 MULTICAP 50:25:25 | -0.8% | -8.3% | 7.2% |
NIFTY MID SMALL400 | -1.5% | -9.7% | 7.3% |
NIFTY SMALLCAP250 | -3% | -12.7% | 6.4% |
NIFTY FREE SMALL 100 | -3.4% | -15.2% | -3.9% |
You may also like the below Video Courses
FAQ about ROSSARI BIOTECH
Is ROSSARI BIOTECH good for long term investment?
As on May 27,2022, the Fundamentals of ROSSARI BIOTECH look Strong and hence it may be good for long term investment! See Financial Performance of ROSSARI BIOTECH . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!Is ROSSARI BIOTECH UnderValued or OverValued?
As on May 27,2022, ROSSARI BIOTECH is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!What is the Intrinsic Value of ROSSARI BIOTECH ?
As on May 27,2022, the Intrinsic Value of ROSSARI BIOTECH is Rs. 77.86 determined based on Median of the 3 historical models.Fair Value [Median EV / EBIDTA Model] : Rs. 77.86
Fair Value [Median EV / Sales Model] : Rs. 65.02
Fair Value [Median Price / Sales Model] : Rs. 2,396.26
Median Fair Value of ROSSARI BIOTECH : Rs. 77.86
Is ROSSARI BIOTECH trading at a Premium or Discount?
As on May 27,2022, ROSSARI BIOTECH is trading at a Premium of 1041% based on the estimates of Median Intrinsic Value!PIDILITE INDUSTRIES LTD vs AARTI INDUSTRIES LTD vs DEEPAK NITRITE LTD
ATUL LTD vs ALKYL AMINES CHEMICALS LTD vs TATA CHEMICALS LTD
NAVIN FLUORINE INTERNATIONAL LTD vs GODREJ INDUSTRIES LTD vs GUJARAT FLUOROCHEMICALS LTD
VINATI ORGANICS LTD vs CLEAN SCIENCE AND TECHNOLOGY LTD vs SOLAR INDUSTRIES INDIA LTD
BALAJI AMINES LTD vs LAXMI ORGANIC INDUSTRIES LTD vs FINE ORGANIC INDUSTRIES LTD
